Protecting our pets from parasites Protecting our pets from parasites Protecting our pets from parasites
Our Four Pillars of Cancer Immunology Research Our Four Pillars of Cancer Immunology Research 我们癌症免疫学研究的四大支柱
FDA approves NexGard for the prevention Lyme disease in dogs FDA approves NexGard for the prevention Lyme disease in dogs FDA approves NexGard for the prevention Lyme disease in dogs
Animal Health Partnering Animal Health Partnering Description Find all our contact information here as well as information on where you can meet us virtually or in person. You can also find out how to submit your opportunity to our BD&L team
2022百靈佳殷格翰以創新藥物推動成長,史無前例地為更多病患提供了藥物 2022百靈佳殷格翰以創新藥物推動成長,史無前例地為更多病患提供了藥物 2022百靈佳殷格翰以創新藥物推動成長,史無前例地為更多病患提供了藥物
結合台灣 ICT 實力與生技新創能量, 百靈佳殷格翰聯手生技中心導入 Grass Roots 計畫 結合台灣 ICT 實力與生技新創能量, 百靈佳殷格翰聯手生技中心導入 Grass Roots 計畫 結合台灣 ICT 實力與生技新創能量, 百靈佳殷格翰聯手生技中心導入 Grass Roots 計畫
禮來與百靈佳殷格翰SGLT2抑制劑再取歐洲批准!首個心衰療法 超越對手AZ 禮來與百靈佳殷格翰SGLT2抑制劑再取歐洲批准!首個心衰療法 超越對手AZ 禮來與百靈佳殷格翰SGLT2抑制劑再取歐洲批准!首個心衰療法 超越對手AZ